Strategies to Facilitate Intravenous Access for Electroconvulsive Therapy Procedures in Pediatric and Neurodivergent Patients: A Case Series [0.03%]
儿科和神经多样性患者电抽搐治疗操作的静脉通路建立策略：一系列病例报告
Adrian Cuellar,Michael E Henry,Joshua R Smith et al.
Adrian Cuellar et al.
Introduction: Electroconvulsive therapy (ECT) is an effective treatment for severe and treatment-resistant psychiatric disorders, particularly depression and catatonia. ECT requires intravenous (IV) access, which can pose a barrier for pedi...
Lifestyle Effects in a Randomized Controlled Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder [0.03%]
注意缺陷多动障碍神经反馈随机对照试验中的生活方式效应
L Eugene Arnold,Kyle Hendrix,Xueliang Pan et al.
L Eugene Arnold et al.
Objectives/Background: Multiple factors influence symptom severity in Attention Deficit/Hyperactivity Disorder (ADHD). We examined four of these: diet, sleep hygiene, exercise, and lighting, in the International Collaborative ADHD Neurofeed...
Definition of Response in Randomized Controlled Trials of Medications for Attention-Deficit/Hyperactivity Disorder Across the Lifespan: A Systematic Review [0.03%]
注意缺陷多动障碍药物随机对照试验中响应定义的系统评价：一生各阶段均适用
Sulagna Roy,Giuseppe Colacicco,Giorgia Frigeri et al.
Sulagna Roy et al.
Objectives: Randomized controlled trials (RCTs) are the gold standard for evaluating medication efficacy. The absence of a universal definition of treatment response, based on the degree of symptom improvement measured by standardized ratin...
High-Frequency Utilization of the Outpatient Messaging System in a Specialized Outpatient Catatonia Clinic for Individuals with Autism Spectrum Disorder [0.03%]
高频利用门诊消息系统进行自闭症谱系障碍患者猫atonia门诊的高频率利用 outpatient messaging system患者的高频利用门诊消息系统进行门诊就诊
Joshua R Smith,Donald G Sengstack,Allison B McCoy et al.
Joshua R Smith et al.
Purpose: Catatonia is a highly morbid psychomotor disorder that impacts autistic adults and children. There is very little literature that describes outpatient catatonia management practices, none of which discusses the use of the electroni...
Letter: Food and Drug Administration Clearance of Transcranial Magnetic Stimulation for Adolescent Depression in the Absence of Data Supporting Efficacy [0.03%]
LETTER：缺少支持有效性的数据美国食品和药物管理局批准经颅磁刺激治疗青少年抑郁症
Kristina T Kumpf,Marcus Hughes,Michael H Bloch
Kristina T Kumpf
Determining Clinically Meaningful Improvement in Children and Adolescents with Tourette Syndrome Receiving Pharmacotherapy [0.03%]
确定接受药物治疗的抽动障碍儿童和青少年临床改善幅度的方法
Joseph F McGuire,George B Karkanias,Richard M Bittman et al.
Joseph F McGuire et al.
Introduction: Accurate assessment of treatment outcomes in patients with Tourette syndrome (TS) is essential for evidence-based clinical care. This report determined the minimal clinically important difference (MCID) on the Yale Global Tic ...
From the Editor-in-Chief's Desk: Navigating Flawed Dogma in Child and Adolescent Psychopharmacology [0.03%]
主编来信：儿科及青少年精神药理学中缺陷教条之我见
Paul E Croarkin
Paul E Croarkin
Michelle Wilson,Francis Wong
Michelle Wilson
Background: SPTAN1 variants are thought to affect the scaffolding that protects the axonal segment of neurons as well as neuronal synapses. The SPTAN1 gene is located in the 9q34.11 genomic region and encodes the cytoskeletal protein alpha ...
Does Concomitant Psychostimulants Mitigate Second-Generation Antipsychotics-Associated Weight Gain? An Observational Study Based on Electronic Medical Records Data [0.03%]
共病刺激剂是否缓解第二代抗精神病药物致体重增加？基于电子病历资料的观察性研究
Ning Lyu,Paul J Rowan,Tyler J Varisco et al.
Ning Lyu et al.
Objective: Weight loss is a well-documented adverse effect of psychostimulants. Given their frequent coprescription with second-generation antipsychotics (SGA) in pediatric patients, this study aims to examine whether concomitant use of psy...